| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |